(Q44071643)

29 November 2017

Imipramine treatment up-regulates the expression and function of mGlu2/3 metabotropic glutamate receptors in the rat hippocampus (English)

1 reference

29 November 2017

Matrisciano F

1

1 reference

29 November 2017

Storto M

2

1 reference

29 November 2017

Ngomba RT

3

1 reference

29 November 2017

Cappuccio I

4

1 reference

29 November 2017

Caricasole A

5

1 reference

29 November 2017

Scaccianoce S

6

1 reference

29 November 2017

Riozzi B

7

1 reference

29 November 2017

Melchiorri D

8

1 reference

29 November 2017

Nicoletti F

9

1 reference

29 November 2017

1 June 2002

1 reference

29 November 2017

1 reference

29 November 2017

42

1 reference

29 November 2017

8

1 reference

29 November 2017

1008-1015

1 reference

Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900057-6

Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900057-6

Cloning and characterization of the human phosphoinositide-specific phospholipase C-beta 1 (PLC beta 1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900057-6

Expression and coupling to polyphosphoinositide hydrolysis of group I metabotropic glutamate receptors in early postnatal and adult rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900057-6

Long-term imipramine effects are prevented by NMDA receptor blockade.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900057-6

(2S,1'R,2'R,3'R)-2-(2,3-dicarboxycyclopropyl) glycine positively modulates metabotropic glutamate receptors coupled to polyphosphoinositide hydrolysis in rat hippocampal slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900057-6

Increased adenylyl cyclase type 1 mRNA, but not adenylyl cyclase type 2 in the rat hippocampus following antidepressant treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900057-6

The changing landscape of ischaemic brain injury mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900057-6

Alterations of tubulin function caused by chronic antidepressant treatment in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900057-6

Imipramine and phenelzine decrease glutamate overflow in the prefrontal cortex--a possible mechanism of neuroprotection in major depression?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900057-6

Regulation of effectors by G-protein alpha- and beta gamma-subunits. Recent insights from studies of the phospholipase c-beta isoenzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900057-6

Antidepressant treatments in the 21st century

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900057-6

(2s,1'R,2'R,3'R)-2-(2,3-Dicarboxycyclopropyl) glycine enhances quisqualate-stimulated inositol phospholipid hydrolysis in hippocampal slices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900057-6

Coupling of inositol phospholipid metabolism with excitatory amino acid recognition sites in rat hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900057-6

Ca2+ antagonists effect an antidepressant-like adaptation of the NMDA receptor complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900057-6

Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900057-6

Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900057-6

The metabotropic glutamate receptors: structure and functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900057-6

Pharmacological agents acting at subtypes of metabotropic glutamate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900057-6

The novel metabotropic glutamate receptor agonist 2R,4R-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: evidence for a synergistic interaction between group 1 and group 2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900057-6

Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900057-6

Tricyclic antidepressants block NMDA receptor-mediated synaptic responses and induction of long-term potentiation in rat hippocampal slices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900057-6

An antidepressant-induced decrease in the responsiveness of hippocampal neurons to group I metabotropic glutamate receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900057-6

10.1016/S0028-3908(02)00057-6

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference